The Research and Development team at Silence Therapeutics Plc focuses on advancing RNA interference technologies to develop innovative gene therapies. This multidisciplinary group, comprising scientists and medical experts, works collaboratively to design, test, and refine drug candidates for various disease applications, ensuring rigorous scientific standards and effective drug discovery processes. Their efforts aim to translate cutting-edge research into viable therapeutic solutions.
View all